Electrotherapy device cleared for pain-relief market

Dave Pearson | September 27, 2011 | Health Exec | Digital Transformation

Zynex, a maker of medical devices used in pain therapy and stroke rehab, has received 510(k) clearance to sell its NexWave neuromuscular-stimulation product.

In announcing the government’s go-ahead, the company said the new product provides a variety of pain and muscle rehabilitation therapies.

Thomas Sandgaard, the company’s CEO, said the device falls under existing medical billing codes.

Zynex is headquartered in Lone Tree, Colo.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Electrotherapy device cleared for pain-relief market

Related Content

Around the web